DARE
Income statement / Annual
Last year (2024), Daré Bioscience, Inc.'s total revenue was $9.78 K,
a decrease of 99.65% from the previous year.
In 2024, Daré Bioscience, Inc.'s net income was -$4.05 M.
See Daré Bioscience, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$9.78 K |
$2.81 M |
$10.00 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$766.00 K |
$0.00 |
| Cost of Revenue |
$513.33 K
|
$38.36 K
|
$47.62 K
|
$26.41 K
|
$43.23 K
|
$11.14 K
|
$625.00 K
|
$0.00
|
$400.00 K
|
$192.00 K
|
| Gross Profit |
-$14.30 M
|
$2.77 M
|
$9.95 M
|
-$26.41 K
|
-$43.23 K
|
-$11.14 K
|
-$2.44 K
|
$0.00
|
$366.00 K
|
-$192.00 K
|
| Gross Profit Ratio |
-1461.1
|
0.99
|
1
|
0
|
0
|
0
|
0
|
0
|
0.48
|
0
|
| Research and Development Expenses |
$14.21 M
|
$21.54 M
|
$30.04 M
|
$30.62 M
|
$20.77 M
|
$8.55 M
|
$6.41 M
|
$984.75 K
|
$27.57 M
|
$25.95 M
|
| General & Administrative Expenses |
$9.16 B
|
$12.11 M
|
$11.24 M
|
$8.45 M
|
$6.63 M
|
$5.80 M
|
$5.28 M
|
$2.71 M
|
$10.36 M
|
$11.22 M
|
| Selling & Marketing Expenses |
-$9.15 B
|
$0.00
|
$0.00
|
$561.00 K
|
$435.00 K
|
$223.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.64 M
|
$12.11 M
|
$11.24 M
|
$8.35 M
|
$6.55 M
|
$5.27 M
|
$5.28 M
|
$2.71 M
|
$10.36 M
|
$11.22 M
|
| Other Expenses |
$100.00 K
|
$100.00 K
|
$100.00 K
|
$0.00
|
$1.51 K
|
$81.05 K
|
$143.50 K
|
$7.49 B
|
$0.00
|
$0.00
|
| Operating Expenses |
$23.46 M
|
$33.61 M
|
$41.39 M
|
$39.07 M
|
$27.40 M
|
$13.81 M
|
$11.70 M
|
$3.69 M
|
$37.92 M
|
$37.17 M
|
| Cost And Expenses |
$23.46 M
|
$33.75 M
|
$41.39 M
|
$39.07 M
|
$27.40 M
|
$14.35 M
|
$16.88 M
|
$3.69 M
|
$37.92 M
|
$37.17 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$86.00 K
|
$10.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$322.63 K
|
$2.24 M
|
$2.43 M
|
| Depreciation & Amortization |
$42.33 K
|
$38.36 K
|
$24.20 K
|
$26.41 K
|
$43.23 K
|
$11.14 K
|
$2.44 K
|
$2.73 M
|
$261.00 K
|
$192.00 K
|
| EBITDA |
-$23.41 M |
-$30.90 M |
-$31.36 M |
-$39.04 M |
-$27.36 M |
-$14.33 M |
-$11.69 M |
-$11.18 M |
-$36.81 M |
-$36.97 M |
| EBITDA Ratio |
-2392.58
|
-11.01
|
-3.14
|
0
|
0
|
0
|
0
|
0
|
-48.05
|
0
|
| Operating Income Ratio |
-2396.92
|
-11.02
|
-3.14
|
0
|
0
|
0
|
0
|
0
|
-48.5
|
0
|
| Total Other Income/Expenses Net |
$19.40 M
|
$678.49 K
|
$437.75 K
|
$372.41 K
|
$1.51 K
|
$81.05 K
|
$143.50 M
|
-$323.00 K
|
-$2.15 M
|
-$2.42 M
|
| Income Before Tax |
-$4.05 M
|
-$30.16 M
|
-$30.95 M
|
-$38.70 M
|
-$27.40 M
|
-$14.26 M
|
-$16.74 M
|
-$11.50 M
|
-$39.31 M
|
-$39.59 M
|
| Income Before Tax Ratio |
-414.35
|
-10.74
|
-3.09
|
0
|
0
|
0
|
0
|
0
|
-51.31
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$437.75 M
|
-$370.00 K
|
-$163.00 K
|
-$161.00 K
|
$10.23 M
|
-$7.17 M
|
$86.00 K
|
$10.00 K
|
| Net Income |
-$4.05 M
|
-$30.16 M
|
-$30.95 M
|
-$38.33 M
|
-$27.40 M
|
-$14.26 M
|
-$16.74 M
|
-$11.50 M
|
-$39.31 M
|
-$39.59 M
|
| Net Income Ratio |
-414.31
|
-10.74
|
-3.09
|
0
|
0
|
0
|
0
|
0
|
-51.31
|
0
|
| EPS |
-0.48 |
-4.15 |
-4.39 |
-7.52 |
-10.93 |
-10.99 |
-30.16 |
-3.56 |
-14.2 |
-15.57 |
| EPS Diluted |
-0.48 |
-4.15 |
-4.39 |
-7.52 |
-10.93 |
-10.99 |
-30.16 |
-3.56 |
-14.2 |
-15.57 |
| Weighted Average Shares Out |
$8.50 M
|
$7.28 M
|
$7.05 M
|
$5.10 M
|
$2.51 M
|
$1.30 M
|
$894.37 K
|
$269.36 K
|
$2.77 M
|
$2.54 M
|
| Weighted Average Shares Out Diluted |
$8.50 M
|
$7.28 M
|
$7.05 M
|
$5.10 M
|
$2.51 M
|
$1.30 M
|
$894.37 K
|
$269.36 K
|
$2.77 M
|
$25.43 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
